These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 2517867)

  • 1. The immune-dependence of chemotherapy in experimental schistosomiasis.
    Doenhoff MJ
    Mem Inst Oswaldo Cruz; 1989 Oct; 84 Suppl 1():31-7. PubMed ID: 2517867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-schistosome chemotherapy enhanced by antibodies specific for a parasite esterase.
    Doenhoff MJ; Modha J; Lambertucci JR
    Immunology; 1988 Dec; 65(4):507-10. PubMed ID: 3146547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for an immune-dependent action of praziquantel on Schistosoma mansoni in mice.
    Doenhoff MJ; Sabah AA; Fletcher C; Webbe G; Bain J
    Trans R Soc Trop Med Hyg; 1987; 81(6):947-51. PubMed ID: 3140436
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune-dependent chemotherapy of schistosomiasis.
    Fallon PG; Cooper RO; Probert AJ; Doenhoff MJ
    Parasitology; 1992; 105 Suppl():S41-8. PubMed ID: 1308928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal differences in praziquantel- and oxamniquine-induced tegumental damage to adult Schistosoma mansoni: implications for drug-antibody synergy.
    Fallon PG; Fookes RE; Wharton GA
    Parasitology; 1996 Jan; 112 ( Pt 1)():47-58. PubMed ID: 8587801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel.
    Fallon PG; Doenhoff MJ
    Parasite Immunol; 1995 May; 17(5):261-8. PubMed ID: 7675513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of praziquantel and oxamniquine treatment on human isotype responses to Schistosoma mansoni: elevated IgE to adult worm.
    Webster M; Fallon PG; Fulford AJ; Butterworth AE; Ouma JH; Kimani G; Dunne DW
    Parasite Immunol; 1997 Jul; 19(7):333-5. PubMed ID: 9278946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
    Brindley PJ; Sher A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A trial to enhance the efficiency of Cyclosporin A in the treatment of Schistosoma mansoni infection by immunization of mice.
    Elkerdany ED; Ebrahim ER; Negm AY
    J Egypt Soc Parasitol; 1998 Aug; 28(2):511-22. PubMed ID: 9707680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosoma mansoni: reduced efficacy of chemotherapy in infected T-cell-deprived mice.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1985 Dec; 60(3):348-54. PubMed ID: 3935473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of host antibody in the chemotherapeutic action of praziquantel against Schistosoma mansoni: identification of target antigens.
    Brindley PJ; Strand M; Norden AP; Sher A
    Mol Biochem Parasitol; 1989 May; 34(2):99-108. PubMed ID: 2496307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schistosoma mansoni: chemotherapy of infections of different ages.
    Sabah AA; Fletcher C; Webbe G; Doenhoff MJ
    Exp Parasitol; 1986 Jun; 61(3):294-303. PubMed ID: 3086114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Control of schistosomiasis pathology by combination of Sm28GST DNA immunization and praziquantel treatment.
    Dupré ; Herv M; Schacht AM; Capron A; Riveau G
    J Infect Dis; 1999 Aug; 180(2):454-63. PubMed ID: 10395862
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of treatment of murine Schistosoma mansoni infections with praziquantel and oxamniquine correlates with infection intensity: role of host antibody.
    Fallon PG; Hamilton JV; Doenhoff MJ
    Parasitology; 1995 Jul; 111 ( Pt 1)():59-66. PubMed ID: 7609991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxamniquine, praziquantel and lovastatin association in the experimental Schistosomiasis mansoni.
    Araújo N; Mattos AC; Sarvel AK; Coelho PM; Katz N
    Mem Inst Oswaldo Cruz; 2008 Aug; 103(5):450-4. PubMed ID: 18797757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice.
    Panic G; Ruf MT; Keiser J
    Antimicrob Agents Chemother; 2017 Dec; 61(12):. PubMed ID: 28971860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune dependence of schistosomicidal chemotherapy: an ultrastructural study of Schistosoma mansoni adult worms exposed to praziquantel and immune serum in vivo.
    Modha J; Lambertucci JR; Doenhoff MJ; McLaren DJ
    Parasite Immunol; 1990 May; 12(3):321-34. PubMed ID: 2117266
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Schistosoma mansoni: molecular cloning and sequencing of the 200-kDa chemotherapeutic target antigen.
    Hall TM; Joseph GT; Strand M
    Exp Parasitol; 1995 Mar; 80(2):242-9. PubMed ID: 7534724
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of oxamniquine and praziquantel in the treatment of Schistosoma mansoni infection: a controlled trial.
    Ferrari ML; Coelho PM; Antunes CM; Tavares CA; da Cunha AS
    Bull World Health Organ; 2003; 81(3):190-6. PubMed ID: 12764515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.